![Philina Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philina Lee
Direktor/Vorstandsmitglied bei
DBV TECHNOLOGIES
Profil
Philina Lee is Chief Executive Officer at AdvanCell Isotopes Pty Ltd. since 2026 and Independent Director at DBV Technologies SA since 2025.
Former roles include Independent Director at Fusion Pharmaceuticals, Inc. from 2021 to 2024, Head-US Marketing at Algeta ASA, and SVP & Head-Portfolio Strategy at Blueprint Medicines Corp.
from 2021 to 2022.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from the University of Alberta.
Aktive Positionen von Philina Lee
| Unternehmen | Position | Beginn |
|---|---|---|
| DBV TECHNOLOGIES | Direktor/Vorstandsmitglied | 30.10.2025 |
AdvanCell Isotopes Pty Ltd.
 AdvanCell Isotopes Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a radiopharmaceutical firm | Vorstandsvorsitzender | 01.01.2026 |
Ehemalige bekannte Positionen von Philina Lee
| Unternehmen | Position | Ende |
|---|---|---|
| FUSN PHAR | Direktor/Vorstandsmitglied | 04.06.2024 |
| ALGETA ASA | Corporate Officer/Principal | - |
| BLUEPRINT MEDICINES CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Philina Lee
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
AdvanCell Isotopes Pty Ltd.
AdvanCell Isotopes Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a radiopharmaceutical firm | Commercial Services |
